H E Johnsen
Overview
Explore the profile of H E Johnsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
878
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alzahrani M, El-Galaly T, Hutchings M, Hansen J, Loft A, Johnsen H, et al.
Ann Oncol
. 2016 Mar;
27(6):1095-1099.
PMID: 27002106
Background: The added diagnostic and prognostic value of routine bone marrow biopsy (BMB) in patients with diffuse large B-cell lymphoma (DLBCL) undergoing positron emission tomography combined with computed tomography (PET/CT)...
2.
Laubach J, Garderet L, Mahindra A, Gahrton G, Caers J, Sezer O, et al.
Leukemia
. 2015 Dec;
30(5):1005-17.
PMID: 26710887
The prognosis for patients multiple myeloma (MM) has improved substantially over the past decade with the development of new, more effective chemotherapeutic agents and regimens that possess a high level...
3.
Blijlevens N, de Chateau M, Krivan G, Rabitsch W, Szomor A, Pytlik R, et al.
Bone Marrow Transplant
. 2012 Dec;
48(7):966-71.
PMID: 23241739
This randomized-controlled trial studied the efficacy of palifermin in a chemotherapy-only, high-dose Melphalan (HDM) transplant setting, to reduce oral mucositis (OM) and its sequelae measured by patient-reported outcomes (PRO) and...
4.
Bodker J, Gyrup C, Johansen P, Schmitz A, Madsen J, Johnsen H, et al.
Cytogenet Genome Res
. 2012 Nov;
139(2):80-7.
PMID: 23182917
The Affymetrix cytogenetic 2.7M whole-genome microarray (Cyto2.7M) detects genomic aberrations. The Cyto2.7M array has increased coverage in regions with cancer-related genes, ~4-fold reduced processing time, and 5-fold reduced input requirements...
5.
Paiva B, Perez-Andres M, Vidriales M, Almeida J, De Las Heras N, Mateos M, et al.
Leukemia
. 2011 Jan;
25(4):697-706.
PMID: 21252988
Disappearance of normal bone marrow (BM) plasma cells (PC) predicts malignant transformation of monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM) into symptomatic multiple myeloma (MM). The homing,...
6.
Brimnes M, Vangsted A, Knudsen L, Gimsing P, Gang A, Johnsen H, et al.
Scand J Immunol
. 2010 Nov;
72(6):540-7.
PMID: 21044128
Patients with multiple myeloma (MM) suffer from a general impaired immunity comprising deficiencies in humoral responses, T-cell responses as well as dendritic cell (DC) function. Thus, to achieve control of...
7.
Perez-Andres M, Paiva B, Nieto W, Caraux A, Schmitz A, Almeida J, et al.
Cytometry B Clin Cytom
. 2010 Sep;
78 Suppl 1:S47-60.
PMID: 20839338
A relatively high number of different subsets of B-cells are generated through the differentiation of early B-cell precursors into mature B-lymphocytes in the bone marrow (BM) and antigen-triggered maturation of...
8.
Johnsen H, Geisler C, Juvonen E, Remes K, Juliusson G, Hornsten P, et al.
Bone Marrow Transplant
. 2010 May;
46(1):44-51.
PMID: 20436517
SCF has been shown to synergize with G-CSF to mobilize CD34(+) PBPCs. In this study we report results from this combination after a phase II trial of 32 patients with...
9.
Haack-Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen H, Kastrup J
Scand J Clin Lab Invest
. 2007 Sep;
68(3):192-203.
PMID: 17852829
Objective: Mesenchymal stromal cells (MSCs) from adult bone marrow (BM) are considered potential candidates for therapeutic neovascularization in cardiovascular disease. When implementing results from animal trials in clinical treatment, it...
10.
Svane I, Nikolajsen K, Johnsen H
Scand J Immunol
. 2007 Sep;
66(4):465-75.
PMID: 17850592
The present study analyses the influence of high-dose chemotherapy (HD) and autologous stem cell transplantation on natural and vaccine induced specific immunity in multiple myeloma patients. Peripheral blood was collected...